Cannabinoid-containing compositions and use for treating and preventing diseases
AssigneeMax Biology Co. Ltd.
InventorsSunil SHAH, Sean NGU
Life of this patent
Estimating the term…
Abstract
The invention provides compositions containing a cannabinoid (e.g., cannabidiol) and optionally one or more bioactive agents for the treatment and/or prevention of diseases including ophthalmic diseases or conditions, dermatologic conditions, infections, inflammatory diseases, and vision disorders. The invention also provides compositions and methods of preparing the compositions containing cannabinoids for cosmetic dermatologic applications and a pharmaceutical eluting contact lens. Furthermore, the invention provides delivery vehicles including lipid-polymer particles and methods of preparing the lipid-polymer particles to deliver the compositions to a subject.
Claims32
A pharmaceutical composition for the treatment or prevention of an ophthalmic condition, comprising therapeutically effective amounts of at least one cannabinoid and a pharmaceutically acceptable excipient or carrier wherein the cannabinoid is present in a concentration between about 0.01% to about 10% by weight of the composition.
4-10. (canceled)
(canceled)
15-17. (canceled)
(canceled)
A pharmaceutical composition comprising therapeutically effective amounts of:
- (a) a cannabinoid;
- and
- (b) a parasympathetic agonist.
22-25. (canceled)
(canceled)
A topical composition for the treatment or prevention of a dermatological condition, comprising a therapeutically effective amount of at least one cannabidiol, its analogs, derivatives, or a combination thereof, wherein the cannabidiol, its analogs, derivatives, or a combination thereof is present in a concentration between about 0.001% to about 10% by weight of the composition, and appropriate topical pharmaceutically acceptable excipients or carriers.
29-31. (canceled)
(canceled)
A pharmaceutical composition for the treatment or prevention of bacterial vaginosis, comprising therapeutically effective amounts of at least one cannabinoid or derivatives thereof, and a pharmaceutically acceptable excipient or carrier, wherein the cannabinoid is present in a concentration between about 0.01% to about 30% by weight of the composition.
36-40. (canceled)
42-50. (canceled)
A composition comprising a therapeutically effective amount of a cannabinoid, wherein the pharmaceutical composition is a powder comprising a guest particle adhered to a carrier particle.
52-55. (canceled)
57-72. (canceled)
A composition comprising a therapeutically effective amount of a cannabinoid and micellar water.
Dependencies are inferred from the claim text.